258 related articles for article (PubMed ID: 27234382)
1. Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma.
Udager AM; McHugh JB; Betz BL; Montone KT; Livolsi VA; Seethala RR; Yakirevich E; Iwenofu OH; Perez-Ordonez B; DuRoss KE; Weigelin HC; Lim MS; Elenitoba-Johnson KS; Brown NA
J Pathol; 2016 Aug; 239(4):394-8. PubMed ID: 27234382
[TBL] [Abstract][Full Text] [Related]
2. Sinonasal papillomas: A single centre experience on 137 cases with emphasis on malignant transformation and EGFR/KRAS status in "carcinoma ex papilloma".
Maisch S; Mueller SK; Traxdorf M; Weyerer V; Stoehr R; Iro H; Hartmann A; Agaimy A
Ann Diagn Pathol; 2020 Jun; 46():151504. PubMed ID: 32203683
[TBL] [Abstract][Full Text] [Related]
3. High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma.
Udager AM; Rolland DCM; McHugh JB; Betz BL; Murga-Zamalloa C; Carey TE; Marentette LJ; Hermsen MA; DuRoss KE; Lim MS; Elenitoba-Johnson KSJ; Brown NA
Cancer Res; 2015 Jul; 75(13):2600-2606. PubMed ID: 25931286
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic Significance of EGFR Mutation and HPV Infection in Sinonasal Squamous Cell Carcinoma.
Hongo T; Yamamoto H; Jiromaru R; Nozaki Y; Yasumatsu R; Hashimoto K; Yoneda R; Sugii A; Taguchi K; Masuda M; Nakagawa T; Oda Y
Am J Surg Pathol; 2021 Jan; 45(1):108-118. PubMed ID: 32868526
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas.
Udager AM; McHugh JB; Goudsmit CM; Weigelin HC; Lim MS; Elenitoba-Johnson KSJ; Betz BL; Carey TE; Brown NA
Ann Oncol; 2018 Feb; 29(2):466-471. PubMed ID: 29145573
[TBL] [Abstract][Full Text] [Related]
6. TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.
Brown NA; Plouffe KR; Yilmaz O; Weindorf SC; Betz BL; Carey TE; Seethala RR; McHugh JB; Tomlins SA; Udager AM
Mod Pathol; 2021 Jun; 34(6):1133-1142. PubMed ID: 33203919
[TBL] [Abstract][Full Text] [Related]
7. EGFR and KRAS mutations in Chinese patients with sinonasal inverted papilloma and oncocytic papilloma.
Wang H; Li H; Hu L; Zhou J; Zhai C; Wang D; Sun X
Histopathology; 2019 Aug; 75(2):274-281. PubMed ID: 30916792
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of HPV infection, EGFR exon 20 mutations and LINE1 hypomethylation as risk factors for malignant transformation of sinonasal-inverted papilloma to squamous cell carcinoma.
Sahnane N; Ottini G; Turri-Zanoni M; Furlan D; Battaglia P; Karligkiotis A; Albeni C; Cerutti R; Mura E; Chiaravalli AM; Castelnuovo P; Sessa F; Facco C
Int J Cancer; 2019 Mar; 144(6):1313-1320. PubMed ID: 30411788
[TBL] [Abstract][Full Text] [Related]
9. Oncocytic Schneiderian papilloma-associated adenocarcinoma and KRAS mutation: A case report.
Zhang L; Hu C; Zheng X; Wu D; Sun H; Yu W; Wu Y; Chen D; Lv Q; Zhang P; Li X; Liu H; Wei Y
Medicine (Baltimore); 2018 Jun; 97(23):e11025. PubMed ID: 29879069
[TBL] [Abstract][Full Text] [Related]
10. OSPs and ESPs and ISPs, Oh My! An Update on Sinonasal (Schneiderian) Papillomas.
Bishop JA
Head Neck Pathol; 2017 Sep; 11(3):269-277. PubMed ID: 28321771
[TBL] [Abstract][Full Text] [Related]
11. EGFR mutation and HPV infection in sinonasal inverted papilloma and squamous cell carcinoma.
Cabal VN; Menendez M; Vivanco B; Potes-Ares S; Riobello C; Suarez-Fernandez L; Garcia-Marin R; Blanco-Lorenzo V; Lopez F; Alvarez-Marcos C; Llorente JL; Hermsen MA
Rhinology; 2020 Aug; 58(4):368-376. PubMed ID: 32199023
[TBL] [Abstract][Full Text] [Related]
12. Exome sequencing reveals candidate mutations implicated in sinonasal carcinoma and malignant transformation of sinonasal inverted papilloma.
Viitasalo S; Karhemo PR; Väänänen J; Ilmarinen T; Lilja M; Katainen R; Monni O; Aaltonen LM
Oral Oncol; 2022 Jan; 124():105663. PubMed ID: 34915258
[TBL] [Abstract][Full Text] [Related]
13. Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck.
Sasaki E; Masago K; Fujita S; Hanai N; Yatabe Y
J Pathol Clin Res; 2020 Apr; 6(2):154-159. PubMed ID: 31960612
[TBL] [Abstract][Full Text] [Related]
14. Sinonasal squamous cell carcinoma and EGFR mutations: a molecular footprint of a benign lesion.
Sasaki E; Nishikawa D; Hanai N; Hasegawa Y; Yatabe Y
Histopathology; 2018 Dec; 73(6):953-962. PubMed ID: 30117182
[TBL] [Abstract][Full Text] [Related]
15. Chronic rhinosinusitis with nasal polyps does not harbor KRAS, BRAF, and EGFR mutations.
da Silva Vieira T; Guimarães LM; Diniz MG; Gomes-Fernandes B; Anselmo-Lima WT; Tamashiro E; Bastos-Rodrigues L; De Marco L; Gomez RS; Valera FCP; Gomes CC
J Oral Pathol Med; 2023 May; 52(5):426-430. PubMed ID: 36116035
[TBL] [Abstract][Full Text] [Related]
16. KRAS and BRAF mutations in sinonasal cancer.
López F; García Inclán C; Pérez-Escuredo J; Alvarez Marcos C; Scola B; Suárez C; Llorente JL; Hermsen MA
Oral Oncol; 2012 Aug; 48(8):692-7. PubMed ID: 22459936
[TBL] [Abstract][Full Text] [Related]
17. Sinonasal papillomas: clinicopathologic review of 40 patients with inverted and oncocytic schneiderian papillomas.
Kaufman MR; Brandwein MS; Lawson W
Laryngoscope; 2002 Aug; 112(8 Pt 1):1372-7. PubMed ID: 12172247
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma ex oncocytic Schneiderian (cylindrical cell) papilloma.
Kapadia SB; Barnes L; Pelzman K; Mirani N; Heffner DK; Bedetti C
Am J Otolaryngol; 1993; 14(5):332-8. PubMed ID: 8238761
[TBL] [Abstract][Full Text] [Related]
19. EGFR and BRAF mutations in inverted sinonasal papilloma - a more complex landscape?
Zonnur S; Erbersdobler A; Schneider B
Virchows Arch; 2021 May; 478(5):915-924. PubMed ID: 33048186
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus infection is strictly associated with the metastatic spread of sinonasal squamous-cell carcinomas.
Doescher J; Piontek G; Wirth M; Bettstetter M; Schlegel J; Haller B; Brockhoff G; Reiter R; Pickhard A
Oral Oncol; 2015 Oct; 51(10):929-34. PubMed ID: 26272275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
